Sinovac Biotech Ltd.

NASDAQ: SVA · Real-Time Price · USD
6.47
0.00 (0.00%)
At close: Feb 11, 2025, 6:18 AM

Sinovac Biotech Income Statement

Financials in USD. Fiscal year is undefined.
Fiscal Year Q1 2024 Q3 2023 Q1 2023 Q3 2022 Q1 2022 Q3 2021 Q1 2021
Period Ending Dec 31, 2023 Jun 30, 2023 Dec 31, 2022 Jun 30, 2022 Dec 31, 2021 Jun 30, 2021 Dec 31, 2020
Revenue
307.87M 140.4M 280.47M 1.21B 8.39B 10.98B 327.45M
Cost of Revenue
n/a 188.41M 430.09M 254.36M 440.45M 631.77M 43.52M
Gross Profit
307.87M -48.01M -149.62M 957.93M 7.95B 10.35B 283.93M
Operating Income
-123.05M -430.57M -1.08B 616.85M 7.42B 10.13B 196.92M
Interest Income
55.52M 29.59M 106.82M 84M 71.76M 30.8M 402K
Pretax Income
-89.42M -63.61M -901.17M 926.41M 7.4B 10.16B 198.37M
Net Income
-116.84M 16.92M -370.65M 484.51M 3.36B 5.11B 108.83M
Selling & General & Admin
176.93M 231.43M 671.12M 156.69M 432.04M 162.1M 83.05M
Research & Development
193.38M 151.13M 257.71M 184.39M 101.13M 53.91M 2.66M
Other Expenses
n/a n/a n/a n/a n/a n/a 1.37M
Operating Expenses
370.31M 382.57M 928.84M 341.08M 533.17M 216.01M 86.89M
Interest Expense
2M 264K 641K 623K 1.31M 1.52M 328K
Selling & Marketing Expenses
n/a n/a n/a n/a n/a n/a n/a
Cost & Expenses
430.91M 570.98M 1.36B 595.44M 973.62M 847.77M 130.42M
Income Tax Expense
138.92M -33.6M -198.85M 135.96M 1.53B 1.57B 25.66M
Shares Outstanding (Basic)
99.6M 99.58M 99.5M 99.5M 99.34M 99.29M 98.9M
Shares Outstanding (Diluted)
99.6M 114.23M 99.5M 114.17M 114M 114.01M 113.66M
EPS (Basic)
-1.17 0.17 -3.73 4.87 33.82 51.45 1.09
EPS (Diluted)
-1.17 0.15 -3.73 4.24 29.47 44.80 0.96
EBITDA
-62.45M -346.42M -999.62M 694.61M 7.49B 10.15B 199.78M
EBIT
-87.43M -63.35M -900.53M 927.03M 7.4B 10.16B 198.69M
Depreciation & Amortization
60.6M 84.15M -4.7M 291.03M -4.7M 289.55M 3.15M